Purity percentage gets all the attention on a peptide Certificate of Analysis. It’s the number vendors put in bold, the number researchers compare between suppliers, the number that shows up in marketing copy. It’s also, on its own, close to useless for answering the question that actually matters for anything going into a cell culture, an animal model, or worse, a person: is this vial free of the kind of contamination that can trigger a serious biological response before the peptide itself does anything at all?
That’s what endotoxin testing is for, and it’s the single most consistently skipped quality check in the grey-market peptide supply chain.
What Endotoxins Actually Are
Bacterial endotoxins are fragments of the outer cell wall of gram-negative bacteria — lipopolysaccharides, specifically — that remain biologically active even after the bacteria producing them are dead. That last part is what makes them dangerous in a way that’s easy to underestimate: a manufacturing process can sterilize a solution, killing every living organism in it, and still leave it loaded with endotoxin from bacteria that died earlier in the process. Sterility and endotoxin-free are not the same claim, and a COA that only addresses one of them is not addressing contamination risk completely.
In a research or in vivo setting, endotoxin contamination can trigger immune activation, fever response, and inflammatory cascades unrelated to whatever the peptide itself was supposed to do — which means an endotoxin-contaminated sample doesn’t just carry a safety risk, it can actively corrupt the results of the research it was used for.
How Endotoxin Testing Actually Works
The standard method is the Limulus Amebocyte Lysate test, universally referred to as LAL, governed in the U.S. by USP General Chapter <85>. The test exploits a naturally occurring clotting reaction in the blood cells of horseshoe crabs: when their amebocyte lysate is exposed to endotoxin, it activates a proteolytic enzyme cascade. Depending on the specific method used, that cascade produces a visible gel clot, a measurable color change, or a turbidity shift — and the strength of that reaction correlates directly with how much endotoxin is present.
There are three standard LAL methodologies, in increasing order of precision: gel-clot (a simple pass/fail visual test), turbidimetric (measuring cloudiness as the reaction develops), and chromogenic (measuring a precise color-change endpoint, generally considered the most accurate for quantitative reporting). A COA that states a specific numeric endotoxin value — rather than just “passed” or “endotoxin free” — using the chromogenic or kinetic chromogenic method is giving you meaningfully more information than one that doesn’t.
A newer alternative, recombinant Factor C (rFC), replicates the same reaction using a manufactured version of the key clotting factor instead of harvested horseshoe crab lysate. It’s accepted by the FDA, EMA, and Japanese Pharmacopeia as a valid alternative method, and it’s increasingly used both for animal-welfare reasons and because it avoids lot-to-lot variability inherent to a biologically harvested reagent.
What the Numbers Actually Mean
Endotoxin results are reported in Endotoxin Units, EU. For approved injectable pharmaceuticals, the general regulatory limit is 5 EU per kilogram of body weight per hour of exposure — a limit that gets substantially stricter, down to 0.2 EU/kg, for anything intrathecal (delivered directly into the spinal fluid), because that route bypasses the body’s normal filtering barriers entirely. For research-grade peptide material used in vitro or in early-stage in vivo work, a result under 1 EU/mg is generally considered unlikely to meaningfully affect most assay systems — but “generally unlikely to interfere with an assay” and “safe for injection” are two entirely different bars, and grey-market marketing has a habit of blurring them.
If a COA reports a purity percentage and nothing else — no endotoxin figure, no method, no units — it has told you almost nothing about contamination risk. Purity by HPLC measures how much of the sample is the intended peptide chain relative to synthesis byproducts and degradation. It says nothing about bacterial contamination introduced during synthesis, purification, lyophilization, or packaging.
The Other Quality Problem: The Vial Doesn’t Match the Order
Endotoxin contamination is a manufacturing-process failure. A second, entirely separate category of quality failure shows up further downstream, in fulfillment: vials that simply don’t match what was ordered. Community-reported and independently tested cases in this category include vials labeled as one compound that tested as containing a different one entirely, batch or lot numbers on a shipped vial that don’t match the batch number referenced on the accompanying COA, and multiple customers receiving product from the same “batch” that returned meaningfully different results under independent testing — suggesting the batch label itself was never consistently tracked to begin with.
This is a quality-control and inventory-management failure as much as a fraud issue, and it’s often invisible to the buyer until something prompts independent testing — an unexpected effect, a failed research result, or a community testing initiative flagging the same vendor repeatedly. It’s also, structurally, one of the easiest problems for a disorganized or high-volume grey-market operation to have: when there’s no regulatory requirement to maintain batch traceability, and no external audit checking that the number on the vial matches a real, documented production run, nothing forces that discipline to exist.
What To Actually Look For
A Certificate of Analysis that’s actually documenting the vial in front of you, rather than just decorating a product page, should include: a batch or lot number that’s also printed on the physical vial label, a stated purity percentage backed by an actual HPLC chromatogram image, mass spectrometry data confirming molecular identity, and a specific endotoxin result — a number, a unit, and a stated method (LAL gel-clot, turbidimetric, chromogenic, or rFC) — from a named, independently checkable testing laboratory. If any of those elements is missing, generic, or unverifiable, treat the gap as the finding, not as an oversight.
For a full walkthrough of how to evaluate a vendor and a COA before you order, see our Vendor Guide. For the enforcement and scam-pattern side of the grey market this quality problem sits inside, see the rest of our Grey Market Watch coverage.
This article is educational and does not constitute laboratory, medical, or purchasing advice. Nothing here should be read as encouraging the use of unapproved research compounds for human consumption.